593 followers
Part 3 of 3 $CRVS Potential Novel Immunotherapy Approach to #NASH on top of autoimmune potential for Soquelitinib Paper Links: Update trials #NASH https://t.co/5vzngYk2CB Role T-cells in #NASH https://t.co/98tz5LTNob Th17/Treg switching Soquelitinib: